CITIUS PHARMACEUTICALS, INC. (CTXR) Operating cash flow 2016–2025
CITIUS PHARMACEUTICALS, INC. (CTXR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$26.6MFY2025 · since FY2016: -$5.9M → -$26.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.6M | +5.8% |
| FY2024 | -$28.2M | +3.0% |
| FY2023 | -$29.1M | -2.5% |
| FY2022 | -$28.4M | -17.0% |
| FY2021 | -$24.3M | -43.2% |
| FY2020 | -$16.9M | -36.1% |
| FY2019 | -$12.4M | -9.9% |
| FY2018 | -$11.3M | -42.0% |
| FY2017 | -$8.0M | -35.1% |
| FY2016 | -$5.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice